Page last updated: 2024-08-05 12:52:02

peptide zwitterion

Zwitterionic form of any peptide where, in general, the amino terminus is positively charged and the carboxy terminus is negatively charged.

ChEBI ID: 60466

Members (7)

MemberDefinitionRole
aglucovancomycin bA peptide zwitterion obtained by transfer of a proton from the carboxy to the amino group of vancomycin aglycone.vancomycin aglycone zwitterion; vancomycin aglycone
angiotensin iA peptide zwitterion that is the dizwitterionic form of angiotensin (1-9) having both carboxy groups deprotonated and the aspartyl amino group and arginine side-chain protonated. It is the major species at pH 7.3.angiotensin (1-9) dizwitterion; angiotensin (1-9)
angiotensin iA peptide zwitterion that is the dizwitterionic form of angiotensin I having both carboxy groups deprotonated and the aspartyl amino group and arginine side-chain protonated. It is the major species at pH 7.3.angiotensin I dizwitterion; angiotensin I
angiotensin i, ile(5)-A peptide zwitterion that is the dizwitterionic form of angiotensin I having both carboxy groups deprotonated and the aspartyl amino group and arginine side-chain protonated. It is the major species at pH 7.3.angiotensin I dizwitterion; angiotensin I
enkephalin, leucineA peptide zwitterion obtained by transfer of a proton from the carboxy to the amino terminus of Leu-enkephalin. Major species at pH 7.3.Leu-enkephalin zwitterion; Leu-enkephalin
enkephalin, methionineA peptide zwitterion obtained by transfer of a proton from the carboxy to the amino terminus of Met-enkephalin. Major species at pH 7.3.Met-enkephalin zwitterion; Met-enkephalin
neurotensin (1-8)A peptide zwitterion that is the dizwitterionic form of neurotensin (1-8) having both carboxy groups deprotonated and the side-chains of L-lysyl and L-arginine protonated. It is the major species at pH 7.3.neurotensin (1-8) dizwitterion; neurotensin (1-8)

Research

Studies (14,888)

TimeframeStudies, Drugs in This Class (%)All Drugs %
pre-19905,948 (39.95)18.7374
1990's4,695 (31.54)18.2507
2000's2,052 (13.78)29.6817
2010's1,769 (11.88)24.3611
2020's424 (2.85)2.80

Study Types

Publication TypeStudies, Drugs in This Class (%)All Drugs (%)
Trials205 (1.30%)5.53%
Reviews1,062 (6.71%)6.00%
Case Studies65 (0.41%)4.05%
Observational14 (0.09%)0.25%
Other14,473 (91.49%)84.16%